Primary |
Anxiety |
19.0% |
Dermatitis |
9.5% |
Erythema Multiforme |
9.5% |
Cataract Operation |
7.9% |
Rash |
7.9% |
Drug Exposure During Pregnancy |
6.3% |
Product Used For Unknown Indication |
6.3% |
Postoperative Care |
4.8% |
Pseudomembranous Colitis |
4.8% |
Arthropod Sting |
3.2% |
Dandruff |
3.2% |
Depression |
3.2% |
Dermatitis Atopic |
3.2% |
Anaesthesia |
1.6% |
Blepharitis |
1.6% |
Dermatitis Acneiform |
1.6% |
Dermatitis Contact |
1.6% |
Dermatomyositis |
1.6% |
Eczema |
1.6% |
Eye Operation |
1.6% |
|
Toxic Anterior Segment Syndrome |
16.7% |
Cleft Palate |
6.7% |
Drug Ineffective |
6.7% |
Maternal Drugs Affecting Foetus |
6.7% |
Parkinson's Disease |
6.7% |
Steroid Withdrawal Syndrome |
6.7% |
Urticaria |
6.7% |
Application Site Pain |
3.3% |
Atrioventricular Block Complete |
3.3% |
Bacteraemia |
3.3% |
Dermatitis Acneiform |
3.3% |
Drug Exposure During Pregnancy |
3.3% |
Erythema |
3.3% |
Erythema Multiforme |
3.3% |
Expired Drug Administered |
3.3% |
Genital Rash |
3.3% |
Hypersensitivity |
3.3% |
Maternal Exposure During Pregnancy |
3.3% |
No Adverse Event |
3.3% |
Pain In Jaw |
3.3% |
|
Secondary |
Anxiety |
20.8% |
Dermatitis Atopic |
11.9% |
Eczema Infantile |
8.9% |
Dermatitis |
6.9% |
Eczema |
6.9% |
Alopecia Areata |
5.9% |
Product Used For Unknown Indication |
5.9% |
Premature Labour |
4.0% |
Pruritus |
4.0% |
Fungal Infection |
3.0% |
Hypertension |
3.0% |
Maternal Therapy To Enhance Foetal Lung Maturity |
3.0% |
Bronchopulmonary Aspergillosis |
2.0% |
Depression |
2.0% |
Hepatitis C |
2.0% |
Intertrigo |
2.0% |
Neoplasm Malignant |
2.0% |
Osteoarthritis |
2.0% |
Pain |
2.0% |
Rash |
2.0% |
|
Maternal Drugs Affecting Foetus |
17.6% |
Drug Exposure During Pregnancy |
14.7% |
Skin Papilloma |
8.8% |
Dizziness |
5.9% |
Drug Ineffective |
5.9% |
Maternal Exposure During Pregnancy |
5.9% |
Acute Generalised Exanthematous Pustulosis |
2.9% |
Cleft Palate |
2.9% |
Cushing's Syndrome |
2.9% |
Expired Drug Administered |
2.9% |
Growth Retardation |
2.9% |
Incorrect Drug Administration Duration |
2.9% |
Intentional Drug Misuse |
2.9% |
Kerion |
2.9% |
Liver Function Test Abnormal |
2.9% |
Oesophageal Variceal Ligation |
2.9% |
Off Label Use |
2.9% |
Paranoia |
2.9% |
Pneumonia Staphylococcal |
2.9% |
Pregnancy |
2.9% |
|
Concomitant |
Product Used For Unknown Indication |
40.1% |
Drug Use For Unknown Indication |
6.0% |
Pruritus |
5.4% |
Gastroenteritis |
4.3% |
Gastrooesophageal Reflux Disease |
4.0% |
Hypertension |
4.0% |
Nasopharyngitis |
3.9% |
Insomnia |
3.7% |
Upper Respiratory Tract Infection |
3.2% |
Rash |
2.9% |
Prophylaxis |
2.8% |
Psoriasis |
2.7% |
Breast Cancer |
2.5% |
Metastases To Bone |
2.5% |
Constipation |
2.3% |
Diarrhoea |
2.3% |
Hiv Infection |
2.1% |
Rectal Cancer |
2.0% |
Conjunctivitis |
1.9% |
Pain |
1.6% |
|
Epilepsy |
11.3% |
Pneumothorax |
11.3% |
Intestinal Obstruction |
7.3% |
Urticaria |
6.7% |
Breast Mass |
6.0% |
Swollen Tongue |
6.0% |
Wound Drainage |
6.0% |
Pruritus |
5.3% |
Vomiting |
4.0% |
Zinc Deficiency |
4.0% |
Dyspnoea |
3.3% |
Hyperglycaemia |
3.3% |
Liver Abscess |
3.3% |
Rash |
3.3% |
Renal Failure Acute |
3.3% |
Type 2 Diabetes Mellitus |
3.3% |
Unresponsive To Stimuli |
3.3% |
Urinary Tract Infection |
3.3% |
Acute Myeloid Leukaemia |
2.7% |
Fatigue |
2.7% |
|
Interacting |
Computerised Tomogram |
100.0% |
|
|